<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0027873" disease_type="Disease or Syndrome" abbrv="">Neuromyelitis optica</z:e> (<z:chebi fb="0" ids="52093">NMO</z:chebi> or <z:e sem="disease" ids="C0027873" disease_type="Disease or Syndrome" abbrv="">Devic's syndrome</z:e>) is a rare <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo>, previously considered a multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> variant </plain></SENT>
<SENT sid="1" pm="."><plain>The most important laboratory and clinical features are optic <z:e sem="disease" ids="C0026975" disease_type="Disease or Syndrome" abbrv="">myelitis</z:e> and <z:e sem="disease" ids="C0026976" disease_type="Disease or Syndrome" abbrv="">transverse myelitis</z:e>, associated with <z:e sem="disease" ids="C0027873" disease_type="Disease or Syndrome" abbrv="">neuromyelitis optica</z:e>-IgG antibody (<z:chebi fb="0" ids="52093">NMO</z:chebi>-IgG) positivity </plain></SENT>
<SENT sid="2" pm="."><plain>Subsequent to this immunological test being available, different groups have described the not-so-rare comorbidity of <z:e sem="disease" ids="C0027873" disease_type="Disease or Syndrome" abbrv="">neuromyelitis optica</z:e> with other systemic <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo>, <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> with secondary anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome (APS) in particular </plain></SENT>
<SENT sid="3" pm="."><plain>We describe a patient meeting both the classification criteria for primary APS and the new diagnostic criteria for <z:e sem="disease" ids="C0027873" disease_type="Disease or Syndrome" abbrv="">neuromyelitis optica</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>It's important to diagnose <z:chebi fb="0" ids="52093">NMO</z:chebi> syndrome as both <z:hpo ids='HP_0100653'>optic neuritis</z:hpo> and <z:e sem="disease" ids="C0026976" disease_type="Disease or Syndrome" abbrv="">transverse myelitis</z:e> were also considered neurological complications of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="52093">NMO</z:chebi>-IgG is a new and fundamental test to decide if <z:chebi fb="1" ids="35705">immunosuppressant</z:chebi> therapy is warranted for such patients </plain></SENT>
</text></document>